Source: Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Zamanian (Stanford, United States of America). PAH induced by methamphetamine and other stimulant drugs: an update. Annual Congress 2013 –Ceremony for the ERS Award for Lifetime Achievement in Pulmonary Arterial Hypertension (financially supported by Actelion) followed by Symposium: Drug-induced pulmonary arterial hypertension

Member's Comments

No comment yet.

Related content which might interest you: Understanding nicotine addiction and the health effects of nicotine use Source: Eur Respir Monogr 2021; 90: 18-32 Year: 2021 Pharmacological treatments for tobacco dependence Source: Eur Respir Rev 2008; 17: 192-198 Year: 2008 Effects of novel tobacco and nicotine products on lung health: use and misuse of the evidence Source: International Congress 2019 – E-cigarettes and heated tobacco: a blessing or a curse? The latest scientific update Year: 2019 Nicotine and cannabis use among teenagers: from prevention to treatment. What works? Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction Year: 2021 Tobacco, alcohol and other substances of abuse: rates of experimentation and concomitant use Source: Eur Respir J 2005; 26: Suppl. 49, 607s Year: 2005 Cannabis use is associated with reduced harm perception towards illicit drugs and experimentation with new psychoactive substances among European adolescents and young adults Source: International Congress 2015 – Epidemiology, public health and economics of tobacco Year: 2015 Comparison of nicotine patch and bupropion in treating tobacco dependence Source: Eur Respir J 2005; 26: Suppl. 49, 388s Year: 2005 Roflumilast in coadministration with medications commonly prescribed for COPD: An overview of existing studies Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Nicotine replacements, bupropion and psychoactive groups in the antismoking outclinic center Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002 Effects of inhaled marijuana exposure on lung health Source: International Congress 2015 – The evolving marijuana epidemic Year: 2015 Nicotine addiction in animals : mechanisms and models Source: Research Seminar 2005 - Tobacco Smoking: Harm Reduction Strategies Year: 2005 A pharmacological with nicotine or bupropion versus an integrated pharmacological and psychological program for smoking cessation Source: Eur Respir J 2002; 20: Suppl. 38, 579s Year: 2002 The effect of active and passive smoking on inhaled drugs in respiratory patients Source: Eur Respir Mon; 2008: 42: 100–105 Year: 2008 Effect of treatment for nicotine dependence using bupropion therapy in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 283s Year: 2007 Paracetamol use and asthma: an overview of evidence implicating adult exposure Source: Annual Congress 2012 - Paracetamol and asthma: a causal link? Year: 2012 What are kids experimenting with? Epidemiology and trends of tobacco use and mental effects of nicotine and cannabis use Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction Year: 2021 Inhaled anticholinergic drugs and risk of acute urinary retention Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008 The psychobiology of nicotine dependence Source: Eur Respir Rev 2008; 17: 172-181 Year: 2008 Serotonergic antidepressants in COPD: beneficial or harmful? Source: Eur Respir J, 52 (1) 1801095; 10.1183/13993003.01095-2018 Year: 2018